Krystal Biotech Inc.

NASDAQ: KRYS · Real-Time Price · USD
150.42
0.09 (0.06%)
At close: Aug 15, 2025, 3:59 PM
147.27
-2.09%
After-hours: Aug 15, 2025, 07:11 PM EDT

Krystal Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
146.73M 123.96M 89.16M 52.37M 105.94M 57.16M 10.93M -29.81M -140.41M -135.31M -139.97M -129.73M -115.47M -103.72M -69.57M -58.15M -52.17M -42.64M
Depreciation & Amortization
6.22M 6.66M 6.64M 6.59M 5.93M 4.98M 4.68M 4.26M 4.41M 4.35M 4.05M 3.75M 3.56M 3.25M 2.77M 2.48M 2.17M 2.05M
Stock-Based Compensation
54.27M 53.31M 49.13M 45.62M 40.62M 38.8M 39.93M 39.63M 40.38M 37.24M 33.23M 28.82M 23.43M 19.44M 15.32M 10.74M 8.43M 5.05M
Other Working Capital
24.74M 27.37M 59.15M 57.97M 33.3M -823K -4.36M -11.58M -2.25M -14.95M 4.07M -2.4M 524K 27.53M 1.34M 8.54M 6.07M 3.67M
Other Non-Cash Items
-24.35M 66.45M 67.55M 114.17M 113.57M 40.81M 39.63M -5.59M -3.7M -1.97M -690K 1.85M 1.89M 1.92M 3.54M 2.42M 2.45M 2.45M
Deferred Income Tax
n/a n/a n/a -46.3M -146.31M -146.31M -146.31M -100M n/a n/a n/a -2.05M -2.05M -2.05M -2.05M -928K -929K -928K
Change in Working Capital
12.54M -39.29M -14.46M -34.51M -61.9M -40.19M -37.68M -12.4M -3.04M -15.54M 2.81M -1.78M 1.94M 27.4M 2.05M 8.37M 5.47M 4.5M
Operating Cash Flow
195.4M 138.5M 123.42M 63.34M -16.74M -46.76M -88.8M -103.9M -102.36M -111.23M -100.57M -99.14M -86.71M -53.78M -47.94M -35.06M -34.57M -29.51M
Capital Expenditures
-9.96M -9.18M -4.24M -5.28M -6.02M -7.68M -11.8M -15.17M -27.44M -41.17M -52.98M -88.64M -95.58M -83.05M -68.34M -34.66M -17.85M -15.81M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-507.71M -507.21M -457.74M -397.17M -390.54M -451.54M -508.78M -529.94M -491.5M -401.6M -318.78M -321.36M -278.16M -253.22M -190.46M -83.81M -59.57M -1.24M
Sales Maturities Of Investments
333.83M 323.73M 298.54M 312.64M 346.26M 412.31M 503.21M 532.7M 486.59M 388.16M 257.68M 174.59M 115.9M 54.34M 32.03M 12.02M 5.43M 6.42M
Other Investing Acitivies
435K 435K n/a n/a 100M 100M 100M 100M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-183.4M -192.23M -163.44M -89.82M 49.7M 53.09M 82.64M 87.59M -32.34M -54.61M -114.08M -235.41M -257.84M -281.93M -226.77M -106.45M -71.99M -10.62M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-4.88M 3.96M 27.01M 24.59M 34.73M 24.09M 12.76M 12.76M -749K -749K -649K -649K -649K -649K -7.96M -7.96M -7.96M -7.96M
Financial Cash Flow
-4.88M 3.96M 27.01M 27.2M 37.23M 211.86M 202.75M 203.2M 191.93M 37.36M 35.35M 234.35M 233.74M 202.84M 347.69M 145.75M 144.41M 262.08M
Net Cash Flow
8.04M -50.24M -13.46M 725K 69.91M 218.26M 196.43M 186.83M 57.16M -128.56M -179.35M -100.2M -110.81M -132.87M 72.98M 4.25M 37.85M 221.95M
Free Cash Flow
185.44M 129.32M 119.18M 58.06M -22.76M -54.44M -100.6M -119.07M -129.81M -152.4M -153.55M -187.78M -182.29M -136.83M -116.27M -69.72M -52.42M -45.32M